| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 2230200-76-5 | methyl 2-(chloromethyl)-3-(((2S)-oxetan-2-yl)methyl)benzimidazole-5-carboxylate | C14H15ClN2O3 |
| 2230475-63-3 | Kdm4-IN-4;(1R,2S,3R,4S)-3-((dimethylamino)methyl)-1-phenylbicyclo(2.2.1)heptan-2-ol | C16H23NO |
| 2230697-41-1 | NRF2 activator-1;ethyl (3S)-3-(7-methoxy-1-methylbenzotriazol-5-yl)-3-(4-methyl-3-(((4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1?6,2-benzoxathiazepin-2-yl)methyl)phenyl)propanoate | C30H34N4O6S |
| 2230788-58-4 | meCgPPh Pd G3;((1,3,5,7-Tetramethyl-6-phenyl-2,4,6-trioxa-6-phosphaadamantane)-2-(2'-amino-1,1'-biphenyl))palladium(II) methanesulfonate | C29H34NO6PPdS |
| 2230788-63-1 | TrixiePhos Pd G3;Mesyl(2-(di-tert-butylphosphino)-1,1'-binaphthyl)(2-(2'-amino-1,1'-biphenyl))palladium(II) | C41H44NO3PPdS |
| 2230788-66-4 | (4-(2-(bis(tricyclo(3.3.1.13,7)dec-1-yl)phosphino-κP)phenyl)morpholine)(methanesulfonato-κO)(2'-(methylamino-κN)(1,1'-biphenyl)-2-yl-κC)-Palladium | C44H57N2O4PPdS |
| 2230788-67-5 | Mesylate((di(1-adamantyl)-n-butylphosphine)-2-(2'-amino-1,1'-biphenyl))palladium(II);cataCXium Pd G4 | C38H54NO3PPdS |
| 2230800-88-9 | Eltrombopag Impurity 40;methyl 3'-amino-2'-hydroxy-(1,1'-biphenyl)-3-carboxylate | C14H13NO3 |
| 2230836-55-0 | N-((R)-1-(3-amino-5-(trifluoromethyl)phenyl)ethyl)-7-methoxy-2-methyl-6-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-4-amine | C26H41P |
| 2230840-12-5 | 7-methoxy-2-methyl-6-((3S)-oxolan-3-yl)oxy-6H-quinazolin-4-one | C14H16N2O4 |
| 2230840-47-6 | (R)-1-(3-Nitro-5-(trifluoromethyl)phenyl)ethan-1-amine hydrochloride;(1R)-1-(3-nitro-5-(trifluoromethyl)phenyl)ethanamine;hydrochloride | C9H10ClF3N2O2 |
| 2230901-24-1 | (3-Amino-2-methylphenyl)boronic acid hydrochloride | C7H10BNO2.HCl |
| 2231663-53-7 | (2R)-2-(tert-butoxycarbonylamino)-2-(3,3-difluorocyclobutyl)acetic acid | C11H17F2NO4 |
| 2231747-18-3 | N-piperidine Ibrutinib hydrochloride;3-(4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo(3,4-d)pyrimidin-4-amine hydrochloride | C15H26N2O6 |
| 2231764-75-1 | Mometasone EP Impurity S;6Ryw63P5NH;((8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta(a)phenanthren-17-yl) furan-2-carboxylate | C27H30Cl2O6 |
| 2238831-60-0 | Datopotamab deruxtecan | |
| 2239295-71-5 | PBDB-T-2Cl;PCE14; Poly((4,8-bis(5-(2-ethylhexyl)-4-chloro-2-thienyl)benzo(1,2-b:4,5-b')dithiophene-2,6-diyl)-2,5-thiophenediyl(5,7-bis(2-ethylhexyl)-4,8-dioxo-4H,8H-benzo(1,2-c:4,5-c')dithiophene-1,3-diyl)-2,5-thiophenediyl) | (C68H76C12O2S8)n |
| 2241140-83-8 | 4-Fluoro-4-(trifluoromethyl)piperidine hydrochloride (1:1) | C6H10ClF4N |
| 2241720-34-1 | 7-Bromo-2,4-dichloro-8-fluoro-6-iodoquinazoline | C8HBrCl2FIN2 |
| 2241721-74-2 | 7-Bromo-8-fluoro-6-iodoquinazoline-2,4(1H,3H)-dione | C8H3BrFIN2O2 |
| 2242426-49-7 | 2-((Tert-butoxycarbonyl)amino)-4,4,4-trifluoro-3,3-dimethylbutanoic acid;4,4,4-trifluoro-3,3-dimethyl-2-((2-methylpropan-2-yl)oxycarbonylamino)butanoic acid | C11H18F3NO4 |
| 2243785-97-7 | Posaconazole Enantiomer 1;4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one | C37H42F2N8O4 |
| 2244103-96-4 | Edoxaban N-oxide;N'-(5-chloropyridin-2-yl)-N-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-((5-methyl-5-oxido-6,7-dihydro-4H-(1,3)thiazolo(5,4-c)pyridin-5-ium-2-carbonyl)amino)cyclohexyl)oxamide | C24H30ClN7O5S |
| 2244777-12-4 | Tinosporol A | C21H26O8 |
| 2244777-15-7 | Tinosporoside A | C27H36O12 |
| 2244986-82-9 | Tamsulosin EP Impurity C;DE(ethoxy)tamsulosin;2-methoxy-5-((2R)-2-(2-phenoxyethylamino)propyl)benzenesulfonamide | C18H24N2O4S |
| 2245111-15-1 | 4,6-Dichloro-pyridazine-3-carboxylic acid lithium salt monohydrate | C5H3Cl2LiN2O3 |
| 2245238-80-4 | Lithium 4,6-Dichloropyridazine-3-carboxylate | C5HCl2LiN2O2 |
| 2245335-70-8 | (2S,3aS,6R,7aS)-3a-Methyl-2-((perfluorophenyl)thio)-6-(prop-1-en-2-yl)hexahydrobenzo(d)(1,3,2)oxathiaphosphole 2-sulfide | C16H16F5OPS3 |
| 2245335-71-9 | (2R,3aR,6S,7aR)-3a-Methyl-2-((perfluorophenyl)thio)-6-(prop-1-en-2-yl)hexahydrobenzo(d)(1,3,2)oxathiaphosphole 2-sulfide | C16H16F5OPS3 |
| 2246363-09-5 | 8-Chloro-7-fluoro-6-iodoisoquinolin-3-amine | C9H5ClFIN2 |
| 2246363-11-9 | (2-Chloro-3-fluoro-4-iodophenyl)methanamine | C7H6ClFIN |
| 2247372-59-2 | (2R,4R)-2-(2-chlorophenyl)-3-(4-(3,5-dimethylisoxazol-4-yl)benzoyl)thiazolidine-4-carboxylic acid | C22H19ClN2O4S |
| 2248628-93-3 | Elagolix Lactam Impurity;(R)-5-(2-fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-3-(2-(2-oxopyrrolidin-1-yl)-2-phenylethyl)pyrimidine-2,4(1H,3H)-dione | C32H28F5N3O4 |
| 2250243-23-1 | Vonoprazan Fumarate Impurity 1;1-(5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl)-N-((5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl)methyl)-N-methylmethanamine | C33H27F2N5O4S2 |
| 2250243-41-3 | Indacaterol Impurity 3;5-(2-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-ethoxyethyl)-8-hydroxy-1H-quinolin-2-one | C26H32N2O3 |
| 2252153-95-8 | Salbutamol EP Impurity H;4-(2-(tert-Butylamino)ethyl)-2-methylphenol hydrochloride | C13H22ClNO |
| 2252237-87-7 | 1-Bromo-4-chlorodibenzo(b,d)furan | C12H6BrClO |
| 2252493-06-2 | DBCO-SH;N-(3-(2-azatricyclo(10.4.0.04,9)hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-3-oxopropyl)-3-sulfanylpropanamide | C21H20N2O2S |
| 2253964-85-9 | Linagliptin Impurity 5;7-but-2-ynyl-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(((3S)-piperidin-3-yl)amino)purine-2,6-dione | C25H28N8O2 |
| 2253969-12-7 | 3,9-Diamino-benzo(1,2-b:4,5-b')bis(1)benzothiophene-5,5,11,11-tetraoxide | C18H12N2O4S2 |
| 2254447-02-2 | Benzo(d)(1,3)dioxole-5-carbonyl fluoride | C8H5FO3 |
| 2257421-80-8 | Progesterone EP Impurity L;20-Methylidene-3-oxopregn-4-en-21-al;2-((8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta(a)phenanthren-17-yl)prop-2-enal | C22H30O2 |
| 2259708-00-2 | Sacubitril-(2R,4R)-Isomer;4-(((2R,4R)-1-((1,1'-Biphenyl)-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid | C24H29NO5 |
| 2261008-21-1 | Naphtho(2,3-b)benzofuran-1-ylboronic acid | C16H11BO3 |
| 2269476-12-0 | 5,8-Dibromo-6,7-difluoro-2-((2-hexyldecyl)oxy)quinoxaline | C24H34Br2F2N2O |
| 2269476-13-1 | PTQ10;5,8-dibromo-6,7-difluoro-2-(2-hexyldecoxy)quinoxaline trimethyl-(5-trimethylstannylthiophen-2-yl)stannane | C34H54Br2F2N2OSSn2 |
| 2271228-51-2 | Acetamide Baricitinib Impurity;2-(3-(4-(1H-pyrazol-4-yl)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-1- (ethylsulfonyl)azetidin-3-yl)acetonitrile hydrochloride | C16H19N7O3S |
| 2271228-52-3 | Baricitinib Acetic Acid Impurity;{1-(Ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-azetidinyl}acetic acid | C16H18N6O4S |
| 2271411-87-9 | Ibandronate Impurity 3;Tetrasodium (1-hydroxy-3-(methyloxido(pentyl)azanyl)propane-1,1-diyl)bis(phosphonate) | C9H19NO8P2 .4Na |